logo

For the Inventor, By the Inventor

Heidelberg, Germany

Dieter Herrmann

This inventor holds 16 USPTO granted patents, primarily in Lipid Chemistry. Top assignees: Boehringer Mannheim Gmbh, Roche Diagnostics Gmbh, Heidelberg Pharma Ag. Active years: 1991-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Herrmann. Retrieved from https://idiyas.com/inventor/dieter-herrmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 87.5

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 285(Granted Patents)


Company Filing History:

goldMedal8 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
silverMedal3 out of 489 
 
Roche Diagnostics Gmbh
 patents
bronzeMedal2 out of 2 
 
Heidelberg Pharma Ag
 patents
4. 3 out of 834,601 
Other
 patents

Years Active: 1991-2008

Loading Chart...
Areas of Expertise:
Nucleotide Lipid Esters
Lipid Cleavage Enzyme
Immunosuppressive Drugs
Phospholipid Derivatives
Nucleoside Conjugates
Lipid Alcohols
Covalent Conjugates
Pharmaceutical Compositions
Antiviral Applications
Lipid Esters
Lipid-Phosphono Conjugates
Imidazolidine Derivatives
16 patents (USPTO):Explore Patents
1. 7419965 - Nucleotide lipid ester derivatives (2008-09-02),
2. 7176011 - Lipid cleavage enzyme (2007-02-13),
3. 6372725 - Specific lipid conjugates to nucleoside diphosphates and their use as drugs (2002-04-16),
4. 6177469 - Lipid alcohols as new immunosuppressive and antiviral drugs (2001-01-23),
5. 6136797 - Phospholipid derivatives of phosphono-carboxylic acids, the production (2000-10-24),
6. 6080734 - Liponucleotides of seco-nucleosides, their production as well as their (2000-06-27),
7. 6025343 - Lipid esters of nucleoside monophosphates and their use as (2000-02-15),
8. 5955452 - Covalent lipid-phosphono-carboxylic acid conjugates and application (1999-09-21),
9. 5770593 - Method of determining a pharmaceutical combination preparations for use (1998-06-23),
10. 5756711 - Phospholipid derivatives of nucleosides and their use as anti-viral (1998-05-26),
11. 5578590 - Pharmaceutical composition preparation for use in inhibiting protein (1996-11-26),
12. 5563257 - Phospholipid derivatives of nucleosides (1996-10-08),
13. 5543402 - [3-(C.sub.16 -C.sub.18)-alkanesulphinyl and (1996-08-06),
14. 5369119 - Use of imexon as an immune suppressive and pharmaceutical compositions (1994-11-29),
15. 5158942 - Process of using phospholipid derivatives to inhibit multiplication of (1992-10-27),

Title: Dieter Herrmann: Innovator in Pharmaceutical Chemistry

Introduction

Dieter Herrmann is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work primarily focuses on developing innovative compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, Herrmann has developed nucleotide lipid ester derivatives. These specific lipid esters of halogenated nucleotides possess anti-cancer properties. The invention includes pharmaceutical compositions containing these compounds, methods for synthesizing them, and their application in treating malignant tumors. Another notable patent involves a lipid cleavage enzyme, which is a membranous enzyme extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. This enzyme can be utilized to prepare medicaments that direct pharmacologically active substances to target cells, enhancing their efficacy.

Career Highlights

Throughout his career, Dieter Herrmann has worked with notable companies, including Boehringer Mannheim GmbH. His expertise in pharmaceutical chemistry has led to advancements in drug development and therapeutic solutions.

Collaborations

Dieter Herrmann has collaborated with esteemed colleagues such as Harald Zilch and Elmar Bosies, contributing to various research projects and innovations in the field.

Conclusion

Dieter Herrmann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of innovative therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…